4.5 Article

Novel Bu4N+Br- catalyzed one-pot multi-component synthesis of 2-amino nicotinonitriles in aqueous medium

Related references

Note: Only part of the references are listed.
Article Chemistry, Inorganic & Nuclear

A concise and versatile synthesis of 2-amino-3-cyanopyridine derivatives in 2,2,2-trifluoroethanol

Samad Khaksar et al.

JOURNAL OF FLUORINE CHEMISTRY (2012)

Review Chemistry, Multidisciplinary

A facile strategy for the synthesis of highly substituted imidazole using tetrabutyl ammoniumbromide as catalyst

C. Kurumurthy et al.

RESEARCH ON CHEMICAL INTERMEDIATES (2012)

Article Chemistry, Medicinal

Synthesis and anti-tumor activity of 2-amino-3-cyano-6-(1H-indol-3-yl)-4-phenylpyridine derivatives in vitro

Fan Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54

Toshitake Kobayashi et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives

Omaima M. Abdelhafez et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Article Chemistry, Organic

An improved synthesis of Biginelli-type compounds via phase-transfer catalysis

Bahar Ahmed et al.

TETRAHEDRON LETTERS (2009)

Article Chemistry, Medicinal

2-amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists

Monica Mantri et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore

Jinxia Deng et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2007)

Article Chemistry, Medicinal

Synthesis and structure-activity relationships of novel IKK-β inhibitors.: Part 2:: Improvement of in vitro activity

T Murata et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)

Article Chemistry, Medicinal

Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors.: Part 1

T Murata et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)